Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $22.86M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RZLT | REZOLUTE INC | 1,986,818 | $18.68M | 81.7% | $8.14 | -18.2% | COM NEW | 76200L309 |
| GLD | SPDR GOLD TR | 7,286 | $2.59M | 11.3% | $310.70 | — | GOLD SHS | 78463V107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 651 | $327K | 1.4% | $401.81 | +20.5% | CL B NEW | 084670702 |
| — | MIND MEDICINE MINDMED INC | 27,011 | $318K | 1.4% | $8.91 | — | COM NEW | 60255C885 |
| ELVN | ENLIVEN THERAPEUTICS INC | 13,097 | $268K | 1.2% | $18.93 | +6.5% | COM | 29337E102 |
| CMPX | COMPASS THERAPEUTICS INC | 53,503 | $187K | 0.8% | $3.22 | -1.9% | COM | 20454B104 |
| BCAX | BICARA THERAPEUTICS INC | 10,941 | $173K | 0.8% | $25.50 | -56.1% | COM | 055477103 |
| KYTX | KYVERNA THERAPEUTICS INC | 22,981 | $138K | 0.6% | $23.94 | -83.3% | COM | 501976104 |
| LXEO | LEXEO THERAPEUTICS INC | 17,332 | $115K | 0.5% | $13.31 | -63.7% | COM | 52886X107 |
| IKT | INHIBIKASE THERAPEUTICS INC | 16,393 | $26,557 | 0.1% | $2.49 | -30.6% | COM NEW | 45719W205 |
| SABS | SAB BIOTHERAPEUTICS INC | 10,935 | $21,979 | 0.1% | $2.26 | 0.0% | COM NEW | 78397T202 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $17,829 | 0.1% | $1.72 | -53.0% | COM | 21077P108 |